跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
therapeutic antibody (COVID-19)
首页
药物
therapeutic antibody (COVID-19)
therapeutic antibody (COVID-19)
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
COVID-19 coronavirus recombinant S1 protein and application thereof
申请人: BEIJING PAIDICHANG TECH DEVELOPMENT CO LTD
优先权: 2020
CN
HYALURONAN IS A DRIVER OF COVID-19 SEVERITY
申请人: UNIV VIRGINIA PATENT FOUNDATION
优先权: 2021
US
HYPERIMMUNE IGG AND/OR IGM COMPOSITIONS AND METHOD FOR PREPARING THEREOF AND METHOD FOR OBTAINING HYPERIMMUNE HUMAN PLASMA FROM A DONOR
申请人: GRIFOLS WORLDWIDE OPERATIONS LTD
优先权: 2020
CN
US
2 件公开
SARS-CoV-2 spike protein antibody and application thereof
申请人: ANYUAN MEDICINE SCIENCE AND TECH SHANGHAI LIMITED COMPANY
优先权: 2020
CN
Anti-SARS-CoV-2 virus monoclonal antibody and application thereof
申请人: ANYUAN MEDICINE SCIENCE AND TECH SHANGHAI LIMITED COMPANY
优先权: 2020
CN
Antibodies against SARS-CoV-2 coronavirus S protein and uses thereof
申请人: ANYUAN MEDICINE SCIENCE AND TECH SHANGHAI LIMITED COMPANY
优先权: 2020
CN
SARS-CoV-2 virus neutralizing antibodies and uses thereof
申请人: ANYUAN MEDICINE SCIENCE AND TECH SHANGHAI LIMITED COMPANY
优先权: 2020
CN
Anti-SARS-CoV-2 virus monoclonal antibody and application thereof
申请人: ANYUAN PHARMACEUTICAL TECH SHANGHAI CO LTD
优先权: 2021
CN
药物
反馈